- STAT+: At a time of tumult at FDA, a former commissioner is hopeful it’s on a better pathWith the FDA facing upheaval and personnel exits, former commissioner David Kessler sees an opportunity whereby the agency can make a turn for the better.STAT · 2mo ago↗ source
- STAT+: TrumpRx adds generic drugsA deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.STAT · 2mo ago↗ source
- STAT+: Dexcom CEO hints at future uses for CGMIn this edition of STAT Health Tech: Takeaways from a conversation with Dexcom CEO, and updates on WiSeR, and Epic's market share.STAT · 2mo ago↗ source